Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference
November 08, 2021 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference
October 27, 2021 09:25 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
October 07, 2021 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
September 10, 2021 09:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
August 09, 2021 16:03 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank
August 09, 2021 16:01 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021
July 02, 2021 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
CORRECTING and REPLACING – Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results
May 10, 2021 17:13 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Organogenesis Holdings Inc. (Nasdaq: ORGO), please note that in the third bullet of...
Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results
May 10, 2021 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Appoints Jon Giacomin to Board of Directors
May 10, 2021 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...